Biotechnology
@Biotechnology
Followers
56K
Following
4
Media
7K
Statuses
55K
BioNTech, Regeneron’s mRNA Cancer Vaccine Combo Clears Phase II in Melanoma https://t.co/gTYdc5X47F
5
3
10
Novo Nordisk’s Ozempic Could Help Curb Cigarette Use in Diabetics: Study https://t.co/b7cwvMPB8t
2
1
7
AstraZeneca’s Calquence Aces Phase III CLL Trial, Eyes Fixed-Duration Approval https://t.co/KtrXZpydGs
0
0
5
Ventyx Ends Development of TYK2 Inhibitor After Phase II Flop in Crohn’s Disease https://t.co/cUx2h3MD4J
0
0
3
Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline https://t.co/tZYCZnrlyJ
1
0
1
WuXi AppTec Hit With Slight Drop in US Revenue as Threat of BIOSECURE Act Looms https://t.co/6iEYzz7514
0
0
1
FDA Flags Safety Risks of Compounded Versions of Novo’s Semaglutide, Reports Hospitalizations https://t.co/g7t2wGywdf
1
0
3
AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff https://t.co/IWrP2dmP3C
0
0
2
Merck’s Keytruda in Combo With Padcev Granted CHMP Positive Opinion in Urothelial Carcinoma https://t.co/jlC34Y34Lj
0
0
4
Adaptimmune Gears Up for Potential Approval of First-in-Class Engineered T Cell Therapy https://t.co/6Fxxa6cv1m
1
0
3
EU Regulatory Panel Recommends Against Approval of Eisai, Biogen’s Leqembi for Alzheimer’s https://t.co/HQ7j807nQe
0
0
1
BMS Gets Q2 Beat, Raises Full-Year Guidance as Cost-Cutting Initiative Continues https://t.co/80OYzq4tkt
0
0
1
Roche to Accelerate Development of Obesity Assets from $2.7B Carmot Buy https://t.co/h7VzU2qaTy
0
0
0